Literature DB >> 19889786

Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2.

Jennifer L Umbach1, Kening Wang, Shuang Tang, Philip R Krause, Erik K Mont, Jeffrey I Cohen, Bryan R Cullen.   

Abstract

Deep sequencing of small RNAs isolated from human sacral ganglia latently infected with herpes simplex virus 2 (HSV-2) was used to identify HSV-2 microRNAs (miRNAs) expressed during latent infection. This effort resulted in the identification of five distinct HSV-2 miRNA species, two of which, miR-H3/miR-I and miR-H4/miR-II, have been previously reported. Three novel HSV-2 miRNAs were also identified, and two of these, miR-H7 and miR-H9, are derived from the latency-associated transcript (LAT) and are located antisense to the viral transcript encoding transactivator ICP0. A third novel HSV-2 miRNA, miR-H10, is encoded within the unique long (U(L)) region of the genome, 3' to the U(L)15 open reading frame, and is presumably excised from a novel, latent HSV-2 transcript distinct from LAT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889786      PMCID: PMC2798372          DOI: 10.1128/JVI.01712-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  RNA interference in human cells is restricted to the cytoplasm.

Authors:  Yan Zeng; Bryan R Cullen
Journal:  RNA       Date:  2002-07       Impact factor: 4.942

2.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  The genome sequence of herpes simplex virus type 2.

Authors:  A Dolan; F E Jamieson; C Cunningham; B C Barnett; D J McGeoch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Prediction and identification of herpes simplex virus 1-encoded microRNAs.

Authors:  Can Cui; Anthony Griffiths; Guanglin Li; Lindsey M Silva; Martha F Kramer; Terry Gaasterland; Xiu-Jie Wang; Donald M Coen
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.

Authors:  P R Krause; K D Croen; J M Ostrove; S E Straus
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.

Authors:  Jennifer Lin Umbach; Martha F Kramer; Igor Jurak; Heather W Karnowski; Donald M Coen; Bryan R Cullen
Journal:  Nature       Date:  2008-07-02       Impact factor: 49.962

7.  Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.

Authors:  Shuang Tang; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

Review 8.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

10.  miRBase: microRNA sequences, targets and gene nomenclature.

Authors:  Sam Griffiths-Jones; Russell J Grocock; Stijn van Dongen; Alex Bateman; Anton J Enright
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  37 in total

Review 1.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 2.  Please stand by: how oncolytic viruses impact bystander cells.

Authors:  Leslee Sprague; Lynne Braidwood; Joe Conner; Kevin A Cassady; Fabian Benencia; Timothy P Cripe
Journal:  Future Virol       Date:  2018-08-08       Impact factor: 1.831

Review 3.  Mammalian alphaherpesvirus miRNAs.

Authors:  Igor Jurak; Anthony Griffiths; Donald M Coen
Journal:  Biochim Biophys Acta       Date:  2011-06-28

Review 4.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

5.  Comprehensive analysis of Rhesus lymphocryptovirus microRNA expression.

Authors:  Kasandra J-L Riley; Gabrielle S Rabinowitz; Joan A Steitz
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture.

Authors:  Omar Flores; Sanae Nakayama; Adam W Whisnant; Hassan Javanbakht; Bryan R Cullen; David C Bloom
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 7.  Five questions about viruses and microRNAs.

Authors:  Bryan R Cullen
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

8.  Identification of a novel marine fish virus, Singapore grouper iridovirus-encoded microRNAs expressed in grouper cells by Solexa sequencing.

Authors:  Yang Yan; Huachun Cui; Songshan Jiang; Youhua Huang; Xiaohong Huang; Shina Wei; Weiyi Xu; Qiwei Qin
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing.

Authors:  Shuang Tang; Nini Guo; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.

Authors:  Maria Korom; Katie L Davis; Lynda A Morrison
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.